Clinical Trials
LabCorp Transforms the Clinical Trial Experience And Streamlines the...
LabCorp , a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced new capabilities that will transform...
Clinical Trials
GSK presents positive clinical data on maternal and older...
GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in Phase...
Clinical Trials
Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances...
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the...
Clinical Trials
Johnson & Johnson Temporarily Pauses All Dosing in Our...
At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world....
Clinical Trials
Kodiak begins three phase 3 studies of anti-VEGF antibody...
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first patients...
Clinical Trials
Vir Biotechnology and GSK announce global expansion to Phase...
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care...
Clinical Trials
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate...
FSD Pharma Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide, or...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.